Clinical Trials Browser

Phase 2 × Neutropenia × Thoracic × Clear all

NCT05578326 2026-03-30

Study of Trilaciclib and Lurbinectidin

Phase 2 Recruiting

Lung Neoplasms, Neutropenia, Small Cell Lung Carcinoma

NCT07205536 2025-12-11

ANC-IIT-004

Phase 2 Recruiting

Classical hematologyThoracic

Neutropenia, Thoracic Neoplasms, Febrile Neutropenia

NCT02005458 2018-07-17

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Phase 2 Completed

BreastClassical hematologyThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neutropenia, Febrile Neutropenia

NCT00077311 2016-06-30

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Classical hematologyThoracic

Adenocarcinoma of Lung, Anemia, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia, Drug-Related Side Effects and Adverse Reactions

NCT00050674 2012-12-27

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neutropenia